Spirulina and Mast Cell Biology: FcepsilonRI, IgE, Histamine Release, and Allergy

Mast Cell Differentiation: Kit/SCF and MITF

Mast cells differentiate from bone marrow progenitors (c-Kit+/FcepsilonRI-) that migrate to peripheral tissues and complete differentiation under local microenvironmental signals: SCF (stem cell factor, Kit/CD117 ligand), IL-3, IL-4, and transforming growth factor-beta. The transcription factor MITF (microphthalmia-associated transcription factor) is the master mast cell regulator, driving tryptase (TPSD1), chymase (CMA1), and histidine decarboxylase (HDC) expression. Kit/SCF signalling activates PI3K/Akt, MAPK, and STAT5 for proliferation; IL-33 (from epithelium/stroma) activates ST2 receptor-MyD88-NF-kB to prime mast cell responsiveness.

FcepsilonRI Structure and IgE Sensitisation

The high-affinity IgE receptor FcepsilonRI (mast cells, basophils) is a tetrameric complex: IgE-binding alpha chain, beta chain (FCER1B, signal amplifier), and gamma2 disulfide-linked dimer (ITAMs). IgE binds FcepsilonRI with Kd approximately 10^-10 M (essentially irreversible), sensitising the mast cell to allergen. Allergen crosslinking of IgE-FcepsilonRI complexes triggers clustering: LYN phosphorylates ITAM tyrosines, SYK is recruited and activated (Tyr319/Tyr520), and LAT1/NTAL adaptors assemble the PLCgamma1/Vav1/PI3K/Btk signalosome. Ca2+ influx (via STIM1- Orai1 CRAC channels) drives degranulation.

Immediate Degranulation: Histamine, Tryptase, Heparin

Within seconds to minutes, mast cells release preformed granule contents: histamine (HDC-synthesised from His), beta-tryptase (TPSAB1/TPSB2, serine protease activating PAR-2 on nerves/epithelium), alpha-chymase (CMA1), heparin (GAG anticoagulant), and carboxypeptidase A3 (CPA3). Histamine activates H1R (Gq/PKC/itching) and H1R on endothelium (NO/vasodilation), H2R (Gs/cAMP/gastric acid), and H4R (GPCR on immune cells, chemotaxis). Spirulina extracts (PCB-rich fractions) dose-dependently inhibit IgE-antigen-triggered histamine release from mast cells and basophils in vitro, with mechanisms including Ca2+ influx inhibition and SYK/LYN kinase attenuation.

Late-Phase Mediators: PGD2, LTC4, and Cytokines

3-6 hours post-activation, de novo lipid mediator synthesis occurs: cPLA2 releases arachidonic acid; COX-1/COX-2 (mast cells express both) produce PGD2 (via PTGDS/ hPGDS, binds DP1/DP2/CRTH2), the dominant mast cell prostaglandin driving bronchoconstriction and eosinophil chemoattraction; 5-LOX/FLAP with LTC4 synthase produces LTC4 (converted to LTD4/LTE4 extracellularly), potent bronchoconstrictor. Spirulina's GLA/DGLA substrate shift reduces AA availability (competing DGLA at COX and 5-LOX active sites), producing 15-DGLA and PGE1 instead of PGD2 and LTC4 respectively, attenuating late-phase allergic inflammation.

NF-kB and Mast Cell Cytokine Production

Activated mast cells produce substantial cytokines via NF-kB and NFAT: TNF-alpha (stored preformed and newly synthesised), IL-4, IL-5, IL-13 (driving Th2/IgE responses), IL-6, IL-33, and VEGF-A (angiogenesis). TNF-alpha from mast cells amplifies NF-kB in surrounding cells, creating inflammatory amplification loops. PCB suppression of NF-kB in mast cells thus attenuates cytokine-driven Th2 amplification, consistent with spirulina's documented reduction in total IgE, specific IgE, and eosinophil counts in allergic rhinitis clinical trials.

NFAT-Calcineurin: Ca2+-Driven Transcription

Sustained Ca2+ elevation activates calcineurin (PP2B/calmodulin-dependent phosphatase) to dephosphorylate NFAT (NFATC1-4), allowing nuclear translocation and induction of IL-4, IL-5, IL-13, and TNF-alpha in mast cells. NFAT and AP-1 (c-Fos/c-Jun, activated by DAG/PKC and MAPK) cooperate at composite NFAT-AP-1 binding sites. Ca2+ chelation (BAPTA) or calcineurin inhibition (cyclosporin A/FK506) blocks these cytokines. Spirulina's SERCA2 support (reducing aberrant cytosolic Ca2+ elevation) and STIM1-Orai1 pathway effects (via calcium signalling mechanisms) may attenuate sustained Ca2+ driving NFAT-calcineurin activation.